| Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001–2005 P Pathak, D West, BC Martin, ME Helm, C Henderson Psychiatric Services 61 (2), 123-129, 2010 | 121 | 2010 |
| Mesh complications and failure rates after transvaginal mesh repair compared with abdominal or laparoscopic sacrocolpopexy and to native tissue repair in treating apical prolapse V Dandolu, M Akiyama, G Allenback, P Pathak International urogynecology journal 28, 215-222, 2017 | 47 | 2017 |
| Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician survey M DeKoven, V Bonthapally, X Jiao, A Ganguli, P Pathak, WC Lee, S Ray Journal of comparative effectiveness research 1 (5), 453-463, 2012 | 31 | 2012 |
| Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents LL Lua, P Pathak, V Dandolu Neurourology and Urodynamics 36 (8), 2123-2131, 2017 | 30 | 2017 |
| Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation MH Kim, D Klingman, J Lin, P Pathak, D Battleman Annals of Pharmacotherapy 43 (5), 840-848, 2009 | 29 | 2009 |
| Comparative analysis of overall cost and rate of healthcare utilization among apical prolapse procedures LL Lua, ED Vicente, P Pathak, D Lybbert, V Dandolu International Urogynecology Journal 28, 1481-1488, 2017 | 24 | 2017 |
| Current practice patterns for management of vulvodynia in the United States LL Lua, Y Hollette, P Parm, G Allenback, V Dandolu Archives of gynecology and obstetrics 295, 669-674, 2017 | 24 | 2017 |
| Profiling clinical characteristics and treatment patterns among non-valvular atrial fibrillation patients: a real-world analysis in Dubai, United Arab Emirates M El Kadri, N Bazargani, M Farghaly, R Mohamed, N Awad, A Natarajan, ... Open Medicine Journal 6 (1), 2019 | 12 | 2019 |
| Health resource utilization and costs during the first 90 days following robot-assisted hysterectomy V Dandolu, P Pathak International Urogynecology Journal 29, 865-872, 2018 | 10 | 2018 |
| Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs SR Feldman, E Levi, P Pathak, S Kakatkar, R Balkrishnan Journal of Medical Economics 16 (12), 1405-1413, 2013 | 7 | 2013 |
| Weighing the evidence for pediatric antipsychotic use. P Pathak, D West, BC Martin Psychiatric Services (Washington, DC) 61 (3), 325-325, 2010 | 4 | 2010 |
| Treatment patterns in patients with age-related macular degeneration and diabetic macular edema: A real-world claims analysis in Dubai I Kozak, A Gurbaxani, A Safar, P Rao, A Masalmeh, H Assaf, M Farghaly, ... Plos one 16 (7), e0254569, 2021 | 3 | 2021 |
| Tafasitamab for the Treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the US Real-World Setting K Saverno, KMZ Savill, B Feinberg, J Galvin, P Pathak, S Gordon, ... Blood 142, 265, 2023 | 2 | 2023 |
| PBI4 budget impact analysis of golimumab in adult rheumatoid arthritis patients in Kingdom of Saudi Arabia A Al Jedai, H AL-Mudaiheem, P Pathak, N Awad, O Mohamed, ... Value in Health 22, S47, 2019 | 2 | 2019 |
| First-line fixed-combination psoriasis treatment is associated with lower healthcare costs SR Feldman, E Levi, P Pathak, S Kakatkar, R Balkrishnan Skinmed 14 (4), 266-272, 2016 | 2 | 2016 |
| Robotic sacrocolpopexy for pelvic organ prolapse: nationwide costs, utilization and outcomes ninety days following surgery LL Lua, P Pathak, V Dandolu Clin Obstet Gynecol 5, 1-8, 2019 | 1 | 2019 |
| Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a … M DeKoven, V Bonthapally, WC Lee, P Pathak, X Jiao, S Ray Journal of Clinical Oncology 30 (15_suppl), 570-570, 2012 | 1 | 2012 |
| PHP13 THE TRENDS IN PRESCRIBING OF HERBAL MEDICINES IN AMBULATORY SETTINGS IN THE UNITED STATES 1993-2004 P Pathak, BC Martin Value in Health 3 (10), A25-A26, 2007 | 1 | 2007 |
| 1992P Real-world (RW) characteristics and outcomes in patients (pts) with muscle-invasive urothelial carcinoma (MIUC) treated with adjuvant nivolumab (NIVO) with or without … H Ebrahimi, R Barragan-Carrillo, WS John, S Lucht, T Miller, P Pathak, ... Annals of Oncology 35, S1152, 2024 | | 2024 |
| Real-World Sequential Use of CD19-Directed Therapies for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab Preceding Chimeric Antigen Receptor T … N Epperla, LJ Nastoupil, B Feinberg, P Pathak, T Amoloja, D Gentile, ... Clinical Lymphoma Myeloma and Leukemia 24, S217, 2024 | | 2024 |
